You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Influencing drug molecule and product design using chemical stability knowledge.
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-C-021-Tuesday
- By: OTTOSSON, Jenny (AstraZeneca, Pharmaceutical Sciences, Mölndal, Sweden)
- Co-author(s): Jenny Ottosson: Pharmaceutical Sciences, AstraZeneca, Mölndal, Sweden
Carolyn Stevenson: Pharmaceutical Sciences, AstraZeneca, Mölndal, Sweden
Karin Carlsson: Pharmaceutical Sciences, AstraZeneca, Mölndal, Sweden
Angela Ku: Pharmaceutical Sciences, AstraZeneca, Mölndal, Sweden - Abstract:
Backgrounds
Using experimental data and knowledge of drug molecule characteristics can influence product design, identify risks and any needed mitigation.Aims
In the very early stages of drug development however it can sometimes be hard to see where and how to influence the molecule design based on potential drug product stability concerns, which.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026